Labcorp Holdings (LH) EBITDA (2009 - 2026)

Labcorp Holdings has disclosed EBITDA across 18 years of filings, most recently posting $451.6 million for Q2 2026.

• In Q2 2026, EBITDA rose 14.47% year-over-year to $451.6 million; the TTM figure through Jun 2026 stood at $1.5 billion (up 25.65% YoY), while the FY2025 annual figure was $1.4 billion, up 27.42% from the prior year.
• EBITDA came in at $451.6 million for Q2 2026 at Labcorp Holdings, up from $380.8 million in the prior quarter.
• In the past five years, EBITDA ranged from a high of $687.9 million in Q1 2022 to a low of -$122.8 million in Q4 2023.
• Average EBITDA over 5 years is $308.3 million, with a median of $323.6 million recorded in 2024.
• Year-over-year, EBITDA sank 530.88% in 2023 and soared 276.3% in 2024.
• Over 5 years, EBITDA stood at $28.5 million in 2022, then slumped by 530.88% to -$122.8 million in 2023, then soared by 276.3% to $216.5 million in 2024, then rose by 23.6% to $267.6 million in 2025, then surged by 68.76% to $451.6 million in 2026.
• Per Business Quant data, the three most recent EBITDA figures were $451.6 million in Q2 2026, $380.8 million in Q1 2026, and $267.6 million in Q4 2025.